A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1304-1310

  Venturoli, S ^a,b   Marescalchi, O ^b   Colombo, F M ^a   Macrelli, S ^a   Ravaioli, B ^a   Bagnoli, A ^a   Paradisi, R ^a   Flamigni, C ^a  

^a Institute of Obstetrics and Gynecology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; KETOCONAZOLE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HAIR GROWTH; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033305292     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.4.5591     Document Type: Article

References (42)

1. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism
2. Treatment of hirsutism in women with flutamide
3. Clinical and endocrine effects of flutamide in hyperandrogenic women
4. Clinical efficacy and safety of low-doses of flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism
5. The impact of a pure antiandrogen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism
6. Finasteride in the treatment of hirsutism: New therapeutic perspectives
7. Clinical and hormonal effects of the 5α-reductase inhibitor finasteride in idiopathic hirsutism
8. Clinical and endocrine effects of Finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
9. Outcome of long-term treatment with 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
10. Effects of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women
11. Hormonal and clinical effects of ketoconazole in hirsute women
12. Ketoconazole therapy for women with ache and/or hirsutism
13. Low-dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro
14. Ketoconazole therapy: Hormonal and clinical effects non-tumor hyperandrogenism
15. Use of cyproterone acetate (CPA) in treatment of ache, hirsutism and virilism
16. Further clinical experience in the treatment of hirsutism with cyproterone acetate
17. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: Results of a multicentered Canadian study
18. Long-term management of hirsute patients with cyproterone acetate
19. The use of the anti-androgens in the treatment of hirsutism
20. Cyproterone acetate for severe hirsutism: Results of a double-blind dose-ranging study
21. Diagnostica degli irsutismi: Test dinamici surrenalici
22. Hirsutism: Implications, etiology, and management
23. The hair cycle on the human thigh and upper arm
24. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease
25. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism
26. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial
27. Flutamide in the treatment of hirsutism: Long-term clinical effects, endocrine changes, and androgen receptor behavior
28. Flutamide in the treatment of hirsutism
29. Treatment of hirsutism with flutamide and a low dosage oral contraceptive in polycystic ovarian disease patients
30. Flutamide hepatotoxicity
31. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women
32. Comparison of finasteride vs. spironolactone in the treatment of idiopathic hirsutism
33. Kinetic analysis of human adrenal steroidogenesis by oral ketoconazole
34. Mechanism of inhibition of human testicular steroidogenesis by oral ketoconazole
35. Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism
36. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome
37. Endocrine and metabolic effects of low dose combination of ethinylestradiol and cyproterone acetate in hirsute women
38. Long-term treatment of hirsutism: Desogestrel compared with cyproterone acetate in oral contraceptives
39. Semi-quantitative measurements of body hair in hirsute women compare well with direct diameter measurements or hair shafts
40. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients
41. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women
42. A novel use of spironolactone: Treatment of hirsutism